In a groundbreaking study, researchers have unveiled a promising new drug, DDL-920, which appears to significantly improve cognitive performance and memory in animal models. This advancement holds particular promise for treating Alzheimer’s disease and potentially other neurological and psychiatric disorders. DDL-920’s effectiveness is rooted in its ability to enhance gamma oscillations in the brain. Gamma… Read more